14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
NCV vs NCZ: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Virtus Convertible & Income Fund II (NCZ) captures the overall head-to-head institutional edge over Virtus Convertible & Income Fund (NCV) on higher Unified Composite conviction (34.7/100 SELL vs. 34.3/100 SELL) after splitting the core matrix 2–2 (led by composite factor balance), while NCV wins 1–0 across the 6-pillar growth and valuation breakdown. NCV trades at $13.91 (N/M Forward P/E, N/A operating margin) versus NCZ at $12.93 (N/M Forward P/E, N/A operating margin).
Growth vs. Quality Trade-Off: NCZ earns the overall head-to-head edge with a stronger Unified Composite Score (34.7/100 SELL vs. NCV 34.3/100 SELL) and 0.96β · 25% Vol risk profile, whereas NCV leads top-line expansion (N/A YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.
Defensive Composite Rating Caution: Although NCZ compares more favorably head-to-head, both NCV (34.3/100 SELL) and NCZ (34.7/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: NCV is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 29.8); meanwhile NCZ is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NCV vs NCZ. Trailing 12-month operating profitability (NCV N/A vs NCZ N/A) and valuation multiples (NCV N/M vs NCZ N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with $262.2M market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ NCV vs NCZ Key Questions & Quantitative Answers
As of Nov 16, 2026, Virtus Convertible & Income Fund II (NCZ) captures the overall head-to-head institutional edge over Virtus Convertible & Income Fund (NCV) on higher Unified Composite conviction (34.7/100 SELL vs. 34.3/100 SELL) after splitting the core matrix 2–2 (led by composite factor balance), while NCV wins 1–0 across the 6-pillar growth and valuation breakdown. NCV trades at $13.91 (N/M Forward P/E, N/A operating margin) versus NCZ at $12.93 (N/M Forward P/E, N/A operating margin). Growth vs. Quality Trade-Off: NCZ earns the overall head-to-head edge with a stronger Unified Composite Score (34.7/100 SELL vs. NCV 34.3/100 SELL) and 0.96β · 25% Vol risk profile, whereas NCV leads top-line expansion (N/A YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates. Defensive Composite Rating Caution: Although NCZ compares more favorably head-to-head, both NCV (34.3/100 SELL) and NCZ (34.7/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: NCV is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 29.8); meanwhile NCZ is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
NCV leads the Growth & Scale pillar: NCV posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with NCZ at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, NCV generates N/A in USD-normalized revenue versus N/A for NCZ. In operating R&D and SG&A reinvestment, NCV deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for NCZ.
NCV and NCZ trade at balanced relative valuation multiples. NCV trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas NCZ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NCV (N/A ROE) versus NCZ (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, NCV carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.84β · 22% Vol realized risk). By comparison, NCZ carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.96β · 25% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.